Asthma Allergy Immunology

Asthma Allergy Immunology

2020, Vol 18, Num, 1     (Pages: 051-053)

Successful Desensitization with Ferric Carboxymaltose

Özlem ÖZDEDEOĞLU 1, Kurtuluş AKSU 1, Buket AKDOĞAN 1, Hale ATEŞ 1, Gözde BUHARI 1, İlkay KALKAN 1, Seçkin ÖZGÜL 2, Görkem KAYA 2,

1 Department of Chest Diseases, Division of Allergy, University of Health Sciences, Ankara Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara, Turkey
2 Department of Internal Medicine, University of Health Sciences, Ankara Atatürk Chest Diseases and Chest Surgery Training and Research Hospital, Ankara, Turkey

DOI: 10.21911/aai.460
Viewed: 222
 - 
Downloaded : 104

Parenteral iron treatment is used especially in patients who need urgent treatment, have intolerance symptoms to oral iron therapy, and/ or where therapy with oral iron supplementation is insufficient. Allergic reactions can be observed with intravenous iron containing medicines and they should thus only be administered by trained staff with appropriate resuscitation facilities. The European Medicines Agency does not approve the use of intravenous iron-containing products in patients with previous hypersensitivity reactions to other parenteral iron products in its 2013 recommendations to manage the risk of allergic reactions to intravenous iron-containing medicines. However, it may be an option to administer intravenous iron therapy with desensitization in patients who need urgent treatment, who cannot be treated effectively with oral iron preparations, or display intolerance to these products. Here we present the first case of successful ferric carboxymaltose desensitization in a patient who had suffered a prior reaction with the same medicine.

Keywords : Desensitization, ferric carboxymaltose, hypersensitivity, iron deficiency anemia